Outcomes in early-stage cervical cancer patients with high-risk features on conization followed by low-risk features on radical hysterectomy
Smith, B, Backes, F.J, O'Malley, D.M, Cohn, D.E, Fowler, J.M, Copeland, L.J, Salani, R
Published in Gynecologic oncology (01.06.2017)
Published in Gynecologic oncology (01.06.2017)
Get full text
Journal Article
Change in genetics service model increases ovarian cancer patient referrals and decreases time to consultation: Improving compliance with guideline-based quality care
Senter, L, O'Malley, D.M, Backes, F.J, Copeland, L.J, Fowler, J.M, Salani, R, Cohn, D.E
Published in Gynecologic oncology (01.06.2017)
Published in Gynecologic oncology (01.06.2017)
Get full text
Journal Article
Close vulvar cancer margins are not strongly associated with recurrence or survival
Cosgrove, C.M, ElNaggar, A.C, Sarin, R.H, Hade, E.M, Ulm, M, Blackburn, P, Tillmanns, T, Cohn, D.E, Fowler, J.M
Published in Gynecologic oncology (01.06.2017)
Published in Gynecologic oncology (01.06.2017)
Get full text
Journal Article
Intraperitoneal chemotherapy following neoadjuvant chemotherapy and optimal cytoreductive surgery
Bixel, K, Vetter, M.H, Cohn, D.E, Fowler, J.M, Copeland, L.J, O'Malley, D.M, Salani, R, Backes, F.J
Published in Gynecologic oncology (01.06.2017)
Published in Gynecologic oncology (01.06.2017)
Get full text
Journal Article
The impact of physician burnout on clinical and academic productivity of gynecologic oncologists: A decision analysis
Turner, T.B, Dilley, S.E, Smith, H.J, Huh, W.K, Modesitt, S.C, Rose, S.L, Rice, L.W, Fowler, J.M, Straughn, J.M
Published in Gynecologic oncology (01.06.2017)
Published in Gynecologic oncology (01.06.2017)
Get full text
Journal Article
Time to chemotherapy in ovarian cancer: Compliance with ovarian cancer quality indicators at a National Cancer Institute-designated comprehensive cancer center
ElNaggar, A.C, Liang, M.I, O'Malley, D.M, Hade, E.M, Copeland, L.J, Fowler, J.M, Salani, R, Backes, F.J, Cohn, D.E
Published in Gynecologic oncology (01.06.2017)
Published in Gynecologic oncology (01.06.2017)
Get full text
Journal Article
Neoadjuvant chemotherapy for the treatment of stage IV endometrial adenocarcinoma: A retrospective cohort
ElNaggar, A.C, Neff, R, Ulm, M, Naeem, U, Fowler, J.M, Cohn, D.E, Backes, F.J, Tillmanns, T
Published in Gynecologic oncology (01.06.2017)
Published in Gynecologic oncology (01.06.2017)
Get full text
Journal Article
A phase II, randomized, double-blind, placebo-controlled study of chemo-immunotherapy combination using motolimod with pegylated liposomal doxorubicin in recurrent or persistent ovarian cancer: A Gynecologic Oncology Group partners study
Monk, B.J, Brady, M.F, Aghajanian, C, Lankes, H, Rizack, T, Leach, J.W, Fowler, J.M, Higgins, R.V, Hanjani, P, Morgan, M.A
Published in Gynecologic oncology (01.06.2017)
Published in Gynecologic oncology (01.06.2017)
Get full text
Journal Article
A single institution pilot study for universal Lynch syndrome screening: A key step towards statewide screening and care
Cosgrove, C.M, Backes, F.J, Hampel, H, Salani, R, Copeland, L.J, O'Malley, D.M, Fowler, J.M, Pearlman, R, Cohn, D.E, Goodfellow, P.J
Published in Gynecologic oncology (01.06.2017)
Published in Gynecologic oncology (01.06.2017)
Get full text
Journal Article
Adherence to a standard algorithm results in high negative predictive value of sentinel lymph node assessment using indocyanine green (ICG) and isosulfan blue (ISB) dyes in endometrial cancer
O'Malley, D.M, Salani, R, Cohn, D.E, Copeland, L.J, Fowler, J.M
Published in Gynecologic oncology (01.04.2015)
Published in Gynecologic oncology (01.04.2015)
Get full text
Journal Article
Setting the bar: Compliance with ovarian cancer quality indicators at a National Cancer Institute (NCI)-designated Comprehensive Cancer Center (CCC)
ElNaggar, A.C, Nekkanti, S, O'Malley, D.M, Hade, E.M, Copeland, L.J, Fowler, J.M, Salani, R, Backes, F.J, Cohn, D.E
Published in Gynecologic oncology (01.04.2015)
Published in Gynecologic oncology (01.04.2015)
Get full text
Journal Article
Outcomes in stage III endometrial cancer are similar for chemotherapy +/− radiation in low and high risk histology
Cosgrove, C, Agrawal, G, Copeland, L.J, O'Malley, D.M, Salani, R, Cohn, D.E, Fowler, J.M
Published in Gynecologic oncology (01.04.2015)
Published in Gynecologic oncology (01.04.2015)
Get full text
Journal Article
Outpatient rapid desensitization for gynecologic oncology patients with moderate to severe hypersensitivity reactions to platinums
Li, Q, Cohn, D.E, Rhoades, A.G, Backes, F.J, Copeland, L.J, Fowler, J.M, Salani, R, O'Malley, D.M
Published in Gynecologic oncology (01.04.2015)
Published in Gynecologic oncology (01.04.2015)
Get full text
Journal Article
A phase III trial of maintenance therapy in women with advanced ovarian/fallopian tube/peritoneal cancer after a complete clinical response to first-line therapy: An NRG oncology study
Copeland, L.J, Brady, M.F, Burger, R.A, Rodgers, W.H, Huang, H, Cella, D, Fowler, J.M, Walker, J.L, Tewari, K.S, Bender, D.P, Morris, R.T, Lowery, W.J, Miller, D.S, Dewdney, S.B, Spirtos, N.M, Lele, S.B, Guntupalli, S.R, Ueland, F.R, Glaser, G.E, Mannel, R.S, DiSaia, P.J
Published in Gynecologic oncology (01.06.2017)
Published in Gynecologic oncology (01.06.2017)
Get full text
Journal Article
Outcomes following percutaneous upper gastrointestinal decompressive tube placement for malignant bowel obstruction in ovarian cancer
Rath, K.S, Loseth, D, Muscarella, P, Phillips, G.S, Fowler, J.M, O'Malley, D.M, Cohn, D.E, Copeland, L.J, Eisenhauer, E.L, Salani, R
Published in Gynecologic oncology (01.04.2013)
Published in Gynecologic oncology (01.04.2013)
Get full text
Journal Article
Effect of chemotherapy delays and dose reductions on progression free and overall survival in the treatment of epithelial ovarian cancer
Nagel, C.I, Backes, F.J, Hade, E.M, Cohn, D.E, Eisenhauer, E.L, O'Malley, D.M, Fowler, J.M, Copeland, L.J, Salani, R
Published in Gynecologic oncology (01.02.2012)
Published in Gynecologic oncology (01.02.2012)
Get full text
Journal Article
Which factors predict bowel complications in patients with recurrent epithelial ovarian cancer being treated with bevacizumab?
Richardson, D.L, Backes, F.J, Hurt, J.D, Seamon, L.G, Copeland, L.J, Fowler, J.M, Cohn, D.E, O'Malley, D.M
Published in Gynecologic oncology (01.07.2010)
Published in Gynecologic oncology (01.07.2010)
Get full text
Journal Article
Ascites predicts degree of treatment benefit of bevacizumab in front-line therapy of advanced epithelial ovarian, fallopian tube, and peritoneal cancers
Java, J, Burger, R.A, Bookman, M.A, Fleming, G, Monk, B.J, Walker, J.L, Homesley, H.D, Fowler, J.M, Greer, B.E, Boente, M.P
Published in Gynecologic oncology (01.06.2014)
Published in Gynecologic oncology (01.06.2014)
Get full text
Journal Article